Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Ekso Bionics Holdings Q4 2023 GAAP EPS $(0.220) Misses $(0.110) Estimate, Sales $4.847M Beat $4.773M Estimate

Author: Benzinga Newsdesk | March 04, 2024 05:09pm
Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.220) per share which missed the analyst consensus estimate of $(0.110) by 100 percent. The company reported quarterly sales of $4.847 million which beat the analyst consensus estimate of $4.773 million by 1.55 percent. This is a 36.50 percent increase over sales of $3.551 million the same period last year.

Posted In: EKSO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist